# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Mibampator | 21 | Selectivity index | = | 3 | ALA4303808 | ||||||
2. | Mibampator | 21 | CC50 | = | 8.66 | uM | ALA4303807 | 8.66 ± 1.75 | nM | Homo sapiens | ||
3. | Mibampator | 21 | IC50 | = | 3.28 | uM | ALA4303806 | 5.48 | 3.28 ± 2.04 | nM | Severe acute respiratory syndrome coronavirus 2 | |
4. | Mibampator | 21 | Inhibition | = | 90.06 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
5. | Mibampator | 21 | inhibition | = | 2.97 | % | ALA4808150 | % | Homo sapiens | |||
6. | Mibampator | 21 | inhibition | = | -20.67 | % | ALA4808149 | % | Homo sapiens | |||
7. | Mibampator | 21 | inhibition | = | 0.75 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
8. | Mibampator | 21 | inhibition | = | 0.75 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
9. | Mibampator | 21 | Inhibition | = | 3.574 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
10. | Mibampator | 21 | EC50 | = | 0.15 | uM | ALA1285620 | 6.82 | nM | Homo sapiens |